Topic: research

Dr. Keith Ferdinand and a group of Tulane students
research

HEALTH DISPARITIES

Three years after the COVID-19 pandemic exposed racial and ethnic health disparities nationwide, those disparities continue to exist in American communities of color.

research

Synthetic Skin For Mosquito Study

A research partnership between Tulane and Rice universities has developed gelatin-like patches of fake skin — called hydrogels — to assist in the study of how mosquitoes transmit deadly diseases and which repellents are most effective. The hydrogels eliminate the need for human and animal testing.https://tulane.it/synthetic-skin-mosquito-study

research

Pneumonia Vaccine

School of Medicine researchers Elizabeth Norton and Dr. Jay Kolls have developed a nasal spray vaccine to thwart antibiotic-resistant Klebsiella pneumoniae, a leading cause of bacterial pneumonia. They were awarded a National Institute of Allergy and Infectious Diseases contract worth up to $16 million to bring a nasal spray pneumonia vaccine to Phase 1 clinical trial.https://tulane.it/pneumonia-vaccine

research

Breast Cancer Screenings

A study led by Yixue Shao, health policy and management researcher at the School of Public Health and Tropical Medicine, examined data from nearly 45,000 female Medicaid beneficiaries in Louisiana and found that breast cancer screening rates decreased to nearly zero in April 2020, during the first wave of the COVID-19 pandemic. Rates fully recovered by mid-2021.https://tulane.it/breast-cancer-screenings

research

Chagas Vaccine

Tulane researchers at the School of Public Health and Tropical Medicine and the Tulane National Primate Research Center have developed a Chagas vaccine that safely protects heart function in nonhuman primates. The development is a critical step toward human clinical trials. There is currently no available vaccine for Chagas.https://tulane.it/chagas-vaccine

research

Dementia Risk Linked To Colds

Getting sick often may impact how quickly the brain ages and increase the risk of dementia or other forms of cognitive decline, according to a study led by Elizabeth Engler-Chiurazzi, assistant professor of neurosurgery and behavioral neuroscientist at the School of Medicine. The study found that repeated, intermittent experiences with moderate inflammation, such as that caused by the flu or a common cold, caused impaired cognition.https://tulane.it/dementia-risk-colds

research

Oral Health and HIV

Researchers at the Tulane National Primate Research Center will examine how chronic oral infections affect the severity of HIV infection and the efficacy of antiretroviral therapies used to treat HIV. A $1.9 million grant from the National Institutes of Health will fund this research, which will be led by Prasun Datta, associate professor of microbiology and immunology.https://tulane.it/oral-health-hiv

bronze medal given to research, scholarship and artistic achievement awards
research

Research, Scholarship & Artistic Achievement Second Annual Awards

Tulane’s Research, Scholarship and Artistic Achievement Awards were presented for the second year on Nov. 4, 2022.

research

BRAIN INSTITUTE LEADER

Award-winning neuroscientist Matthew Dalva has been appointed as director of the Tulane Brain Institute and the university’s newest Presidential Chair. Dalva, whose research focuses on how the connections of the brain form and are changed by experience, will succeed Professor Jill Daniel, who has served as director of the institute since its inception in 2016.https://tulane.it/brain-institute-leader

research

OMICRON VACCINE

Researchers at the Tulane National Primate Research Center co-authored a study that shows a new COVID-19 vaccine offers protection against Omicron variants of SARS-CoV-2 for at least six months. The trial tested a vaccine, which is currently in use in South Korea, on nonhuman primates.https://tulane.it/omicron-vaccine